Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2009 Nov;11(6):479-85.
doi: 10.1007/s11908-009-0069-4.

HIV and the Kidney

Affiliations

HIV and the Kidney

Leslie A Bruggeman et al. Curr Infect Dis Rep. 2009 Nov.

Abstract

Direct effects of HIV-1 infection on the kidney combine with immune and genetic factors, comorbidities, coinfections, and medication toxicities to induce a spectrum of kidney disorders in HIV disease. The most dramatic of these, HIV-associated nephropathy (HIVAN), emerges almost exclusively in persons of African descent and is associated with rapid progression to end-stage renal disease in the absence of antiretroviral therapy (ART). ART modifies the natural history of HIVAN, but the renal benefits of ART may not be limited to HIVAN. ART is often under prescribed or incorrectly dosed in persons with kidney disease. Vigilant attention to renal function and an understanding of the complex associations involving the kidneys are necessary for optimal care of these patients.

PubMed Disclaimer

Figures

Figure 1
Figure 1. Histopathology of HIVAN
A. Collapsed glomerulus with greatly enlarged urinary space with evidence of proteinaceous and cellular debris in primary filtrate. B. Tubulointerstitial compartment with tubular atrophy and microcystic tubules, many of which are filled with proteinaceous casts. Interstitial changes also include fibrosis and immune cell infiltrates.

References

    1. Gardner LI, Holmberg SD, Moore J, et al. Use of highly active antiretroviral therapy in HIV-infected women: impact of HIV specialist care. J Acquir Immune Defic Syndr. 2002;29:69–75. - PubMed
    1. Szczech LA, Hoover DR, Feldman JG, et al. Association between renal disease and outcomes among HIV-infected women receiving or not receiving antiretroviral therapy. Clin Infect Dis. 2004;39:1199–1206. - PubMed
    1. Wyatt CM, Arons RR, Klotman PE, et al. Acute renal failure in hospitalized patients with HIV: risk factors and impact on in-hospital mortality. Aids. 2006;20:561–565. - PubMed
    1. Mulenga LB, Kruse G, Lakhi S, et al. Baseline renal insufficiency and risk of death among HIV-infected adults on antiretroviral therapy in Lusaka, Zambia. Aids. 2008;22:1821–1827. ** Documents a high prevalence of renal insufficiency among persons initiating ART through a large treatment program, which was an independent predictor of mortality. - PMC - PubMed
    1. Wools-Kaloustian K, On G’or WO, Wafula S, et al. The relationships between renal dysfunction and clinical outcomes in HIV infected Kenyans not requiring immediate ART [Abstract 741]. Programs and Abstracts of the 16th Conference on Retroviruses and Opportunistic Infections; Montreal, Quebec. 2009. [Accessed 22 February 2009]. Available at: http://www.retroconference.org/